ArticleDermatology and therapy2026

Efficacy and Safety of the First Adalimumab Biosimilar in Chinese Children with Severe Plaque Psoriasis: The PISCES Study, a Multicenter Prospective Study.

Yirong Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.